Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease.
Parkinson's disease
neurorehabilitation
physiotherapy
remote treatment
telehealth
telemedicine
telerehabilitation
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
03
2022
accepted:
06
05
2022
entrez:
5
7
2022
pubmed:
6
7
2022
medline:
6
7
2022
Statut:
epublish
Résumé
Parkinson's disease (PD) patients frequently engage in rehabilitation to ameliorate symptoms. During the Coronavirus disease 2019 (COVID-19) pandemic, access to rehabilitation programs has been markedly limited, consequently, telerehabilitation gained popularity. In this prospective, open-label, and pilot study, we aimed to investigate feasibility, safety, and efficacy of telerehabilitation in mild-to-moderate PD patients. Twenty-three PD patients, with Hoehn and Yahr stage <3, without gait disturbances or dementia and capable of using the televisit platform, were recruited for a 5-week telerehabilitation program, consisting of 1 remote visit with a therapist and a minimum of two sessions of >30-min of self-conducted exercises per week. Patients received video tutorials of exercises and were asked to keep a diary of sessions. At baseline (T0), at the end of the intervention (T1), and 1 month after the end of treatment (T2), patients were remotely assessed with MDS-UPDRS part I-III, PDQ-39, Functional Independence Measure (FIM), and Frontal Assessment Battery scales, respectively. Acceptable compliance to the program was defined as >60% matching of frequency and duration of sessions, whereas optimal compliance was set at >80% matching. The dropout rate was 0%. Over 85% of patients reached acceptable adherence cut-off and around 70% reached optimal one. No adverse events were reported during sessions. The repeated measure analysis of variance (rANOVA) showed a significant effect of factor "time" for MDS-UPDRS-III ( Our findings demonstrate that telerehabilitation is safe, feasible, and effective on motor symptoms in mild-to-moderate PD patients.
Identifiants
pubmed: 35785358
doi: 10.3389/fneur.2022.909197
pmc: PMC9245570
doi:
Types de publication
Journal Article
Langues
eng
Pagination
909197Informations de copyright
Copyright © 2022 Bianchini, Onelli, Morabito, Alborghetti, Rinaldi, Anibaldi, Marcolongo, Salvetti and Pontieri.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Am J Phys Med Rehabil. 2021 May 1;100(5):435-438
pubmed: 33819924
Front Neurol. 2021 Aug 26;12:627999
pubmed: 34512495
Mov Disord. 2021 Nov;36(11):2461-2463
pubmed: 34432329
J Geriatr Psychiatry Neurol. 2021 Jul;34(4):321-330
pubmed: 34219524
J Parkinsons Dis. 2020;10(4):1379-1382
pubmed: 32675421
Mov Disord. 2017 Nov;32(11):1524-1536
pubmed: 29067726
J Neurol. 2022 Feb;269(2):627-638
pubmed: 33449202
Parkinsonism Relat Disord. 2021 May;86:97-100
pubmed: 33895540
Mov Disord. 2019 Feb;34(2):180-198
pubmed: 30653247
BMJ Glob Health. 2020 May;5(5):
pubmed: 32376777
Front Neurol. 2020 Apr 30;11:423
pubmed: 32425880
Mov Disord. 2020 Oct;35(10):1712-1716
pubmed: 32776601
Parkinsonism Relat Disord. 2020 Nov;80:32-34
pubmed: 32937224
JMIR Mhealth Uhealth. 2021 Aug 31;9(8):e27662
pubmed: 34463635
Int J Environ Res Public Health. 2021 Jun 30;18(13):
pubmed: 34208823
Front Neurol. 2020 Jun 24;11:664
pubmed: 32695066
J Parkinsons Dis. 2020;10(4):1779-1786
pubmed: 32894251
Qual Life Res. 1995 Jun;4(3):241-8
pubmed: 7613534
Neurology. 1967 May;17(5):427-42
pubmed: 6067254
Psychosom Med. 2010 Apr;72(3):239-52
pubmed: 20223924
J Parkinsons Dis. 2020;10(4):1365-1377
pubmed: 32925107
Parkinsonism Relat Disord. 2021 Aug;89:128-133
pubmed: 34293534
Mov Disord. 2020 Dec;35(12):2129-2133
pubmed: 32860226
J Parkinsons Dis. 2021;11(s1):S27-S34
pubmed: 33492246
Parkinsonism Relat Disord. 2015 Dec;21(12):1421-6
pubmed: 26578041
Nat Rev Neurosci. 2017 Jul;18(7):435-450
pubmed: 28592904
Neurology. 2000 Dec 12;55(11):1621-6
pubmed: 11113214
Mov Disord Clin Pract. 2021 Jul 11;8(7):1144-1147
pubmed: 34631955
Front Neurol. 2021 Jul 30;12:708433
pubmed: 34393984
Mov Disord. 2015 Sep 15;30(11):1504-20
pubmed: 26274930
Nat Rev Dis Primers. 2017 Mar 23;3:17013
pubmed: 28332488
Adv Clin Rehabil. 1987;1:6-18
pubmed: 3503663
Front Psychiatry. 2020 Nov 27;11:581144
pubmed: 33329124
Neurology. 2014 Jul 29;83(5):413-25
pubmed: 24991037
Telemed J E Health. 2019 Jul;25(7):541-550
pubmed: 30136898
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
J Parkinsons Dis. 2020;10(4):1355-1364
pubmed: 32925108
Neurology. 2008 Jun 3;70(23):2241-7
pubmed: 18519873
JAMA. 2020 Feb 11;323(6):548-560
pubmed: 32044947
Mov Disord Clin Pract. 2020 Aug 17;7(7):797-802
pubmed: 32837960
Front Neurol. 2020 Aug 13;11:846
pubmed: 32903506
Int J Telerehabil. 2021 Jun 22;13(1):e6368
pubmed: 34345343
Mov Disord. 2020 Oct;35(10):1717-1718
pubmed: 32776602
Parkinsonism Relat Disord. 2020 Jun;75:130-132
pubmed: 32723588
Med Sci Sports Exerc. 2007 Nov;39(11):1997-2004
pubmed: 17986908
Telemed J E Health. 2020 Dec;26(12):1533-1536
pubmed: 32667839
Neurol Sci. 2022 Jan;43(1):341-348
pubmed: 33948763
PLoS One. 2018 Feb 27;13(2):e0193113
pubmed: 29486000
Curr Opin Neurol. 2021 Aug 1;34(4):589-597
pubmed: 33990100
NPJ Parkinsons Dis. 2021 Mar 8;7(1):25
pubmed: 33686074
Mov Disord. 2018 Aug;33(8):1248-1266
pubmed: 29570866
Lancet Neurol. 2019 May;18(5):459-480
pubmed: 30879893